Abstract:Abstract OBJECTIVE Dendritic cells (DCs) are important functional antigen-presenting cells that play an essential role in initiating and modulating immune responses. Their mature states are crucial for the induction of T-cell-mediated immune reactions. Therefore, The mechanism of T cell anergy related with DCs and research in applying immature DCs to establish donor-specific immune tolerance have become one of the new frontiers in the field of transplantation immunity. The activation of nuclear factor kappa B(NF-κB) has been said to modulate the maturation of DCs, which controls the transcription of genes encoding major histocompatibility complex(MHC)antigens, and costimulator molecules for T cell activation. The CD47 Ag, a multispan transmembrane ptotein expressed on all hemopoietic cells, has an immunosuppressive function with its ligand, monoclonal antibody (mAb) or thrombospondin. In the current study, we investigate the influence of CD47 engagement by its soluble mAb B6H12 on the maturation and function of cultured DCs. Further to observe any results could be ascribed to the effect of B6H12 mAb on the nuclear translocation and DNA binding of NF-κB. METHODS Monocyte-derived DCs were propagated in granulocyte-macrophage colony stimulating factor (GM-CSF) combined with lipopolysaccharide (LPS) and interleukin(IL)-4, in the presence or absence of soluble anti-CD47 monoclonal antibodies (anti-CD47 mAbs, B6H12). The phenotype of DCs(CD80, CD86, CD83, CD1a, HLA-DR) were detected by the flow cytometry. Semi-quantitative RT-PCR and ELISA methods were used to analyse the mRNA and protein expression levels of interleukin-12(IL-12). The antigen-presenting functions of DCs were determined in one-way mixed leukocyte reaction by Brdu-ELISA. Electrophoretic mobility shift assay (EMSA) was applied to examine the activity of NF-κB. RESULTS Both the immature and the mature DCs express CD47, which has a ratio of 94-98%. The cell immune phenotype was lower in B6H12 mAb treated DC group than that in untreated groups. The data were as follow:CD80+(68.14±7.41)% vs (89.17±8.59)%; CD86+ (67.33±4.71)% vs (87.27±3.56)%;CD83(40.08±14.80)% vs (72.77±8.68)%;Cdla+(66.45±4.06)% vs (95.93±3.03)%; HLA-DR(40.67±13.48) vs (98.97±1.01)%, respectively. The mRNA levels of IL-12 P40 was decreased (P<0.01) with the treatment of B6H12 mAb. Pre-exposure of developing DCs to 10μg/ml B6H12 considerably reduced their subsequent ability to secret IL-12 P70 upon stimulation by LPS, comparing with the other two control groups [(36.6±3.83)pg/ml vs (80.43±8.24)pg/ml vs(83.7±9.58 )pg/ml] (P<0.05). It is also noted that the inhibition of IL-12 P70 release by B6H12 mAb was dependent on dose at the range of 2.5 - 10μg/ml, and the inhibition can be seen in DCs treated with B6H12 mAb at the dose of 2.5μg/ml. The data of the mixed leukocyte reaction were consistent with the flow cytometry results (P<0.01). Pre-exposure to B6H12 mAb during the development of DCs resulted in a dramatic decrease of the DNA binding activity toward protein in the nucleus. Moreover, this inhibition was also seemed to be dose dependent (2.5μg/ml, 5μg/ml, 10μg/ml) and the density scan values were:126.1±4.32, 103.46±10.96, 72.80±10.08. CONCLUSION This results indicate that the CD47 ligation by B6H12 mAb exerts a negative effect on the maturation and function of in vitro cultured DCs through the inhibition of NF-κB binding activity, which suggest its favorable role in the induction of modulation of immune tolerance.

High-Level Expression Of B7-H1 Molecules By Dendritic Cells Suppresses The Function Of Activated T Cells And Desensitizes Allergen-Primed Animals

Engagement of B7 on Effector T Cells by Regulatory T Cells Prevents Autoimmune Disease.

Overexpression of Programmed Death Ligand 1 in Dendritic Cells Inhibits Allogeneic Lymphocyte Activation in Mice

Functional Expression of B7H1 on Pancreatic Carcinoma Panc-1 Cells

B7DC/PDL2 Promotes Tumor Immunity by a PD-1–independent Mechanism

PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade

Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells.

Hrd1-mediated BLIMP-1 ubiquitination promotes dendritic cell MHCII expression for CD4 T cell priming during inflammation

Fas Signal Promotes the Immunosuppressive Function of Regulatory Dendritic Cells Via the ERK/β-catenin Pathway.

Integrin CD11b Negatively Regulates TLR9-triggered Dendritic Cell Cross-Priming by Upregulating Microrna-146A.

Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

Antigen-dependent interactions between regulatory B cells and T cells at the T:B border inhibit subsequent T cell interactions with DCs

Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation

PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer

PD-L1-deficient Mice Show That PD-L1 on T Cells, Antigen-Presenting Cells, and Host Tissues Negatively Regulates T Cells

β-Catenin in Dendritic Cells Negatively Regulates CD8 T Cell Immune Responses through the Immune Checkpoint Molecule Tim-3

The role of B7 molecules in T cell anergy

PD-1 negatively regulates helper T cell differentiation into Th2

PD-1 Shapes B Cells as Evildoers in the Tumor Microenvironment.

PD-1 Expression By Dendritic Cells Is a Key Regulator of T-Cell Immunity in Cancer

CD47 Engagement Impairs the Function and Maturation of Human Dendritic Cells Via the Inhibition of NF-κB Avtivity.